Literature DB >> 19542300

Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response.

Christof Geldmacher1, Ian S Metzler, Sodsai Tovanabutra, Tedi E Asher, Emma Gostick, David R Ambrozak, Constantinos Petrovas, Alexandra Schuetz, Njabulo Ngwenyama, Gustavo Kijak, Leonard Maboko, Michael Hoelscher, Francine McCutchan, David A Price, Daniel C Douek, Richard A Koup.   

Abstract

Human immunodeficiency virus-1 subtypes A and C differ in the highly conserved Gag-TL9 epitope at a single amino acid position. Similarly, the TL9 presenting human leukocyte antigen (HLA) class I molecules B42 and B81 differ only at 6 amino acid positions. Here, we addressed the influence of such minor viral and host genetic variation on the TL9-specific CD8 T-cell response. The clonotypic characteristics of CD8 T-cell populations elicited by subtype A or subtype C were distinct, and these responses differed substantially with respect to the recognition and selection of TL9 variants. Irrespective of the presenting HLA class I molecule, CD8 T-cell responses elicited by subtype C exhibited largely comparable TL9 variant cross-recognition properties, expressed T-cell receptors that used almost exclusively the TRBV 12-3 gene, and selected for predictable patterns of viral variation within TL9. In contrast, subtype A elicited TL9-specific CD8 T-cell populations with completely different, more diverse TCRBV genes and did not select for viral variants. Moreover, TL9 variant cross-recognition properties were extensive in B81(+) subjects but limited in B42(+) subjects. Thus, minor viral and host genetic polymorphisms can dramatically alter the immunologic and virologic outcome of an epitope-specific CD8 T-cell response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542300      PMCID: PMC2731637          DOI: 10.1182/blood-2009-02-206193

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Global epidemiology of HIV.

Authors:  Francine E McCutchan
Journal:  J Med Virol       Date:  2006       Impact factor: 2.327

2.  A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Authors:  Sampa Santra; Bette T Korber; Mark Muldoon; Dan H Barouch; Gary J Nabel; Feng Gao; Beatrice H Hahn; Barton F Haynes; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

3.  De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Xu G Yu; Elizabeth T Kalife; Laura L Reyor; Mathias Lichterfeld; Mina John; Michael Cheng; Rachel L Allgaier; Stanley Mui; Nicole Frahm; Galit Alter; Nancy V Brown; Mary N Johnston; Eric S Rosenberg; Simon A Mallal; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  T cell receptor recognition motifs govern immune escape patterns in acute SIV infection.

Authors:  David A Price; Sadie M West; Michael R Betts; Laura E Ruff; Jason M Brenchley; David R Ambrozak; Yvette Edghill-Smith; Marcelo J Kuroda; Derek Bogdan; Kevin Kunstman; Norman L Letvin; Genoveffa Franchini; Steven M Wolinsky; Richard A Koup; Daniel C Douek
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

5.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.

Authors:  Angel Varela-Rohena; Peter E Molloy; Steven M Dunn; Yi Li; Megan M Suhoski; Richard G Carroll; Anita Milicic; Tara Mahon; Deborah H Sutton; Bruno Laugel; Ruth Moysey; Brian J Cameron; Annelise Vuidepot; Marco A Purbhoo; David K Cole; Rodney E Phillips; Carl H June; Bent K Jakobsen; Andrew K Sewell; James L Riley
Journal:  Nat Med       Date:  2008-11-09       Impact factor: 53.440

Review 6.  CD8+ T cell efficacy in vaccination and disease.

Authors:  Victor Appay; Daniel C Douek; David A Price
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

Review 7.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

8.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

Authors:  Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Xiao-ning Xu; Sirijitt Vasanawathana; Nattaya Tangthawornchaikul; Aroonrung Chairunsri; Siraporn Sawasdivorn; Thaneeya Duangchinda; Tao Dong; Sarah Rowland-Jones; Pa-thai Yenchitsomanus; Andrew McMichael; Prida Malasit; Gavin Screaton
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

9.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

10.  CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.

Authors:  Anita Milicic; David A Price; Peter Zimbwa; Bruce L Booth; Helen L Brown; Philippa J Easterbrook; Kara Olsen; Nicola Robinson; Uzi Gileadi; Andrew K Sewell; Vincenzo Cerundolo; Rodney E Phillips
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

View more
  13 in total

1.  Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.

Authors:  Jaclyn K Wright; Vanessa L Naidoo; Zabrina L Brumme; Jessica L Prince; Daniel T Claiborne; Philip J R Goulder; Mark A Brockman; Eric Hunter; Thumbi Ndung'u
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

Review 2.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

3.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.

Authors:  Asli Bauer; Lilli Podola; Philipp Mann; Marco Missanga; Antelmo Haule; Lwitiho Sudi; Charlotta Nilsson; Bahati Kaluwa; Cornelia Lueer; Maria Mwakatima; Patricia J Munseri; Leonard Maboko; Merlin L Robb; Sodsai Tovanabutra; Gustavo Kijak; Mary Marovich; Sheena McCormack; Sarah Joseph; Eligius Lyamuya; Britta Wahren; Eric Sandström; Gunnel Biberfeld; Michael Hoelscher; Muhammad Bakari; Arne Kroidl; Christof Geldmacher
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.

Authors:  R S Ntale; D R Chopera; N K Ngandu; D Assis de Rosa; L Zembe; H Gamieldien; M Mlotshwa; L Werner; Z Woodman; K Mlisana; S Abdool Karim; C M Gray; C Williamson
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

6.  Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.

Authors:  Paul J McLaren; Stephan Ripke; Kimberly Pelak; Amy C Weintrob; Nikolaos A Patsopoulos; Xiaoming Jia; Rachel L Erlich; Niall J Lennon; Carl M Kadie; David Heckerman; Namrata Gupta; David W Haas; Steven G Deeks; Florencia Pereyra; Bruce D Walker; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

Review 7.  Vaccine design for CD8 T lymphocyte responses.

Authors:  Richard A Koup; Daniel C Douek
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 8.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14

9.  Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.

Authors:  Joseph P Casazza; Kathryn A Bowman; Selorm Adzaku; Emily C Smith; Mary E Enama; Robert T Bailer; David A Price; Emma Gostick; Ingelise J Gordon; David R Ambrozak; Martha C Nason; Mario Roederer; Charla A Andrews; Frank M Maldarelli; Ann Wiegand; Mary F Kearney; Deborah Persaud; Carrie Ziemniak; Raphael Gottardo; Julie E Ledgerwood; Barney S Graham; Richard A Koup
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

10.  A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.

Authors:  Henrik N Kløverpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; Søren Buus; Andrew K Sewell; Philip Goulder
Journal:  Retrovirology       Date:  2015-02-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.